Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/221876
Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread
Títol de la revista
ISSN de la revista
Títol del volum
Resum
High-grade serous ovarian cancer (HGSOC) is the deadliest gynecological malignancy. The most common form of metastatic spread of HGSOC is transcoelomic dissemination. In this process, detached cells from the primary tumor aggregate as tumorspheres and promote the accumulation of peritoneal ascites. This represents an early event in HGSOC development and is indicative of poor prognosis. In this study, based on tumorspheres isolated from ascitic liquid samples from HGSOC patients, ovarian cancer spheroid 3D cultures, and in vivo models, we describe a key signal for tumorsphere formation in HGSOC. We report that platelet-derived growth factor receptor beta (PDGFRβ) is essential for fibronectin-mediated cell clustering of ovarian cancer cells into tumorspheres. This effect is mediated by the kinase NUAK family SNF1-like kinase 1 (NUAK1) and blocked by PDGFRβ pharmacological or genetic inhibition. In the absence of PDGFRβ, ovarian cancer cells can be provided with fibronectin by cancer-associated fibroblasts to generate chimeric spheroids. This work provides new insights that uncover potential targets to prevent peritoneal dissemination, the main cause of advanced disease in HGSOC patients.
Descripció
Matèries
Matèries (anglès)
Citació
Citació
GENDRAU-SANCLEMENTE, Núria, FIGUERAS I AMAT, Agnès, GRACOVA, Kristina, LAHIGUERA, Álvaro, ALSINA SANCHÍS, Elisenda, MARÍN JIMÉNEZ, Juan a., VIDAL-BEL, August, MATIAS-GUIU, Xavier, FERNÁNDEZ GONZÁLEZ, Sergi, BARAHONA, Marc, MARTÍ, Lola, PONCE I SEBASTIÀ, Jordi, VIÑALS CANALS, Francesc. Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread. _Molecular Oncology_. 2023. Vol. 18, núm. 1, pàgs. 136-155. [consulta: 24 de novembre de 2025]. ISSN: 1574-7891. [Disponible a: https://hdl.handle.net/2445/221876]